Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 [(1R) 1 (2,6 dichloro 3 fluorophenyl)ethoxy]pyridin 2 amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105820113B reveals a novel resolution method for Crizotinib intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.